Molecule Holdings Inc.
EVRRF
$0.00
$0.000.00%
OTC PK
| 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -9.13% | -64.83% | 41.52% | 262.57% | 184.23% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -9.13% | -64.83% | 41.52% | 262.57% | 184.23% |
| Cost of Revenue | -47.14% | -77.24% | 11.16% | 249.63% | 52.48% |
| Gross Profit | 369.50% | 100.98% | 31.51% | -238.55% | 69.06% |
| SG&A Expenses | -22.96% | -53.26% | -35.38% | 7.75% | 47.96% |
| Depreciation & Amortization | 308.75% | -6.41% | -6.41% | 39.62% | -36.51% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -34.29% | -65.58% | -19.81% | 87.81% | 49.09% |
| Operating Income | 59.73% | 65.99% | 34.46% | -56.93% | -0.71% |
| Income Before Tax | -2.06% | 34.17% | 52.92% | -76.52% | 36.47% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.06% | 34.17% | 52.92% | -76.52% | 36.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.06% | 34.17% | 52.92% | -76.52% | 36.47% |
| EBIT | 59.73% | 65.99% | 34.46% | -56.93% | -0.71% |
| EBITDA | 73.58% | 78.83% | 38.45% | -63.09% | -3.29% |
| EPS Basic | -1.69% | 34.67% | 53.57% | -72.31% | 39.18% |
| Normalized Basic EPS | -2.70% | 46.81% | 56.76% | -97.30% | 36.21% |
| EPS Diluted | 3.85% | 34.67% | 53.57% | -72.31% | 19.59% |
| Normalized Diluted EPS | -2.70% | 46.81% | 56.76% | -97.30% | 36.21% |
| Average Basic Shares Outstanding | 0.22% | 0.45% | 2.11% | 2.63% | 3.98% |
| Average Diluted Shares Outstanding | 0.22% | 0.45% | 2.11% | 2.63% | 3.98% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |